Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Kindred Biosciences, Inc. (KIN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Kindred Biosciences, Inc. |
| 02/14/2022 |
SC 13G/A
| AMERIPRISE FINANCIAL INC reports a 0% stake in Kindred Biosciences, Inc |
| 09/13/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 09/02/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/31/2021 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in Kindred Biosciences, Inc. |
| 08/30/2021 |
4
| Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 1,709,271 shares
@ $9.25, valued at
$15.8M
Disposed/sold 2,000 shares
@ $9.25, valued at
$18.5k
Disposed/sold 400,000 options to buy
@ $0.36, valued at
$144k
Disposed/sold 350,000 options to buy
@ $16.52, valued at
$5.8M
Disposed/sold 197,771 options to buy
@ $6.46, valued at
$1.3M
Disposed/sold 197,771 options to buy
@ $3.45, valued at
$682.3k
Disposed/sold 175,000 options to buy
@ $6.4, valued at
$1.1M
Disposed/sold 175,000 options to buy
@ $8.75, valued at
$1.5M
Disposed/sold 400,000 options to buy
@ $9.91, valued at
$4M
Disposed/sold 300,000 options to buy
@ $9.84, valued at
$3M
Disposed/sold 394,000 options to buy
@ $4.44, valued at
$1.7M
|
|
| 08/30/2021 |
4
| Wee Wendy (CFO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 78,613 shares
@ $9.25, valued at
$727.2k
Disposed/sold 32,500 options to buy
@ $6.96, valued at
$226.2k
Disposed/sold 10,000 options to buy
@ $3.25, valued at
$32.5k
Disposed/sold 75,000 options to buy
@ $6.4, valued at
$480k
Disposed/sold 50,000 options to buy
@ $7.1, valued at
$355k
Disposed/sold 75,000 options to buy
@ $8.75, valued at
$656.3k
Disposed/sold 100,000 options to buy
@ $9.91, valued at
$991k
Disposed/sold 50,000 options to buy
@ $9.84, valued at
$492k
Disposed/sold 83,500 options to buy
@ $4.44, valued at
$370.7k
|
|
| 08/30/2021 |
4
| Bevers Denise (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 145,835 shares
@ $9.25, valued at
$1.3M
Disposed/sold 20,400 options to buy
@ $0.9, valued at
$18.4k
Disposed/sold 96,092 options to buy
@ $1.37, valued at
$131.6k
Disposed/sold 75,000 options to buy
@ $15.41, valued at
$1.2M
Disposed/sold 59,031 options to buy
@ $6.96, valued at
$410.9k
Disposed/sold 59,031 options to buy
@ $3.45, valued at
$203.7k
Disposed/sold 30,000 options to buy
@ $3.6, valued at
$108k
Disposed/sold 100,000 options to buy
@ $6.4, valued at
$640k
Disposed/sold 100,000 options to buy
@ $8.75, valued at
$875k
Disposed/sold 75,000 options to buy
@ $12.6, valued at
$945k
Disposed/sold 150,000 options to buy
@ $9.91, valued at
$1.5M
|
|
| 08/30/2021 |
4
| Zhan Hangjun (Chief Scientific Officer) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 64,306 shares
@ $9.25, valued at
$594.8k
Disposed/sold 12,000 options to buy
@ $19.96, valued at
$239.5k
Disposed/sold 7,500 options to buy
@ $9.17, valued at
$68.8k
Disposed/sold 8,000 options to buy
@ $6.96, valued at
$55.7k
Disposed/sold 10,000 options to buy
@ $3.25, valued at
$32.5k
Disposed/sold 15,000 options to buy
@ $3.6, valued at
$54k
Disposed/sold 75,000 options to buy
@ $6.4, valued at
$480k
Disposed/sold 50,000 options to buy
@ $7.65, valued at
$382.5k
Disposed/sold 80,000 options to buy
@ $8.75, valued at
$700k
Disposed/sold 100,000 options to buy
@ $9.91, valued at
$991k
Disposed/sold 50,000 options to buy
@ $9.84, valued at
$492k
|
|
| 08/30/2021 |
4
| Veszpremi Ervin (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 40,000 options to buy
@ $0.32, valued at
$12.8k
Disposed/sold 20,000 options to buy
@ $1.37, valued at
$27.4k
Disposed/sold 35,000 options to buy
@ $15.41, valued at
$539.4k
Disposed/sold 44,000 options to buy
@ $6.96, valued at
$306.2k
Disposed/sold 44,000 options to buy
@ $3.45, valued at
$151.8k
Disposed/sold 49,900 options to buy
@ $6.4, valued at
$319.4k
Disposed/sold 75,000 options to buy
@ $8.75, valued at
$656.3k
Disposed/sold 50,000 options to buy
@ $9.91, valued at
$495.5k
Disposed/sold 50,000 options to buy
@ $9.84, valued at
$492k
Disposed/sold 50,000 options to buy
@ $4.44, valued at
$222k
|
|
| 08/30/2021 |
4
| Townsend Raymond (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 24,928 shares
@ $9.25, valued at
$230.6k
Disposed/sold 20,000 options to buy
@ $7, valued at
$140k
Disposed/sold 34,000 options to buy
@ $15.41, valued at
$523.9k
Disposed/sold 44,000 options to buy
@ $6.96, valued at
$306.2k
Disposed/sold 18,892 options to buy
@ $3.45, valued at
$65.2k
Disposed/sold 49,900 options to buy
@ $6.4, valued at
$319.4k
Disposed/sold 75,000 options to buy
@ $8.75, valued at
$656.3k
Disposed/sold 50,000 options to buy
@ $9.91, valued at
$495.5k
Disposed/sold 50,000 options to buy
@ $9.84, valued at
$492k
Disposed/sold 50,000 options to buy
@ $4.44, valued at
$222k
|
|
| 08/30/2021 |
4
| MONTGOMERY HERBERT D (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 27,500 options to buy
@ $3.52, valued at
$96.8k
Disposed/sold 3,350 options to buy
@ $4.14, valued at
$13.9k
Disposed/sold 49,900 options to buy
@ $6.4, valued at
$319.4k
Disposed/sold 75,000 options to buy
@ $8.75, valued at
$656.3k
Disposed/sold 51,500 options to buy
@ $9.91, valued at
$510.4k
Disposed/sold 51,500 options to buy
@ $9.84, valued at
$506.8k
Disposed/sold 51,500 options to buy
@ $4.44, valued at
$228.7k
|
|
| 08/30/2021 |
4
| McCracken Joseph S (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 41,890 options to buy
@ $9.65, valued at
$404.2k
Disposed/sold 10,000 options to buy
@ $11, valued at
$110k
Disposed/sold 48,500 options to buy
@ $9.91, valued at
$480.6k
Disposed/sold 48,500 options to buy
@ $9.84, valued at
$477.2k
Disposed/sold 48,500 options to buy
@ $4.44, valued at
$215.3k
|
|
| 08/30/2021 |
4
| Lien Lyndon (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 47,000 options to buy
@ $5.08, valued at
$238.8k
|
|
| 08/30/2021 |
4
| Liu Nanxi (Director) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Disposed/sold 48,000 options to buy
@ $5.08, valued at
$243.8k
|
|
| 08/30/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/30/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/30/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/30/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/30/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/30/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 08/30/2021 |
4
| Elanco Animal Health Inc (10% Owner) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Bought 45,508,938 shares
@ $9.25, valued at
$421M
|
|
| 08/30/2021 |
8-K
| Quarterly results |
| 08/30/2021 |
SC 13D/A
| Elanco Animal Health Inc reports a 100% stake in Kindred Biosciences, Inc. |
| 08/27/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 08/26/2021 |
8-K
| Quarterly results |
| 08/09/2021 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 08/09/2021 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 08/05/2021 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 4.4% stake in Kindred Biosciences, Inc. |
| 08/05/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 08/04/2021 |
4
| Chin Richard (CEO) has filed a Form 4 on Kindred Biosciences, Inc.|
Txns:
| Gifted 320,000 shares
@ $0
Sold 40,000 shares
@ $9.206, valued at
$368.2k
|
|
| 08/02/2021 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
|
|
|